Rémi Yaïci

Rémi Yaïci

Auto-generated profile, based on publicly available information

Rémi Yaïci

Department of Ophthalmology, Strasbourg University Hospital, NHC, University of Strasbourg, Strasbourg, France

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RYRémi Yaïci
Rémi Yaïci
JPJérémie Poirot
Jérémie Poirot
LDLea Dormegny
Lea Dormegny
NNNicole Neumann
Nicole Neumann
EBEugénie Bazarya
Eugénie Bazarya
TBTristan Bourcier
Tristan Bourcier
This study aims to assess validity evidence of the new phacoemulsification module of the HelpMeSee [HMS] virtual reality simulator. Conducted at the Ophthalmology Department of Strasbourg University Hospital and Gepromed Education Department, Strasbourg, France, this cross-sectional study divided 20 surgeons into two groups based on their experience over or under 300 cataract surgeries. Surgeons filled out a background survey covering their phacoemulsification experience and prior simulator use before undergoing single-session simulations on the EyeSi [EYS] and HMS simulators. Handgrip strength was measured pre- and post-simulation to evaluate grip fatigue. Afterwards, surgeons rated the perceived realism on a seven-point Likert scale. Participants were predominantly right-handed males, with expert surgeons averaging 44 years and intermediate surgeons 29 years of age. Expert surgeons had completed around 2000 phacoemulsification surgeries compared to 150 by intermediates. Primary outcome was to assess the construct validity of HMS simulator based on the difference in total and modules scores between both groups. Significant performance differences were observed between the two groups, with experts scoring higher. HMS scores were 35.8 ± 1.5 out of 46 points for experts and 27.2 ± 2.3 for intermediates (p = 0.006). For EYS, scores were 405.2 ± 20.3 out of 500 points for experts and 327.8 ± 25.2 for intermediates (p = 0.028). Experts experienced significantly less grip fatigue post-simulation on HMS compared to intermediates. This research evaluates validity evidence of HMS’s phacoemulsification modules for the first time. It emphasizes the potential to broaden simulation-based training by targeting diverse populations.

21 April 2022 in Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
LJL. Jürgens
L. Jürgens
RYR. Yaici
R. Yaici
CSC. M. Schnitzler
C. M. Schnitzler
AFA. K. Fleitmann
A. K. Fleitmann
MRM. Roth
M. Roth
RGRainer Guthoff
Rainer Guthoff
Background: Retinal arterial occlusive events in young patients are rare. However, because of physiological multifactorial adaptations during pregnancy, retinal vascular occlusive disease may occur spontaneously. In addition, a patent foramen ovale is a risk factor for an ischemic thromboembolic event. Since fluorescein angiography, a central tool in the evaluation of these occlusions, should be avoided during pregnancy, optical coherence tomography angiography, a novel technique, offers a good opportunity for visualizing vascular perfusion of retinal tissue. Case presentation: Here we present a case series of three patients (Caucasian, nonsmoker) who visited our clinic owing to acute visual impairment and central scotoma. Using regular optical coherence tomography and optical coherence tomography angiography, retinal vascular occlusions were detected, thus initiating the evaluation of systemic risk factors. We report two patients (30 and 32 years old) who developed cilioretinal artery occlusion but whose etiology differed: one was of thromboembolic origin associated with patent foramen ovale, while the other was caused by hemodynamic blockade secondary to central retinal vein occlusion. In both cases, optical coherence tomography angiography revealed reperfusion of the cilioretinal artery occlusion. However, transient ischemia led to retinal atrophy after a few weeks. In the third patient (32 years old), 8 weeks after onset of scotoma, optical coherence tomography angiography revealed atrophy of the middle layers and impaired perfusion in the deep capillary plexus, and thus a paracentral acute middle maculopathy was diagnosed. All patients regained normal visual acuity and had otherwise uncomplicated pregnancies, and laboratory blood tests did not reveal any defects or alterations. Conclusions: As shown here, optical coherence tomography angiography enables risk-free imaging of retinal vessel perfusion during pregnancy. Together with regular optical coherence tomography, it allows one to predict functional outcome according to the existing retinal occlusion-related atrophy.

27 May 2024 in Die Ophthalmologie
Verified
Journal Article
Closed access
RYRémi Yaïci
Rémi Yaïci
MCM. Cieplucha
M. Cieplucha
RBR. Bock
R. Bock
FMF. Moayed
F. Moayed
NBN. E. Bechrakis
N. E. Bechrakis
MRM. Roth
M. Roth

24 May 2022 in Klinische Monatsblätter für Augenheilkunde
Verified
Journal Article
Closed access
PDF file
RYRémi Yaïci
Rémi Yaïci
MRMathias Roth
Mathias Roth
LJLukas Juergens
Lukas Juergens
SNSami Al Nawaiseh
Sami Al Nawaiseh
DBDick Burkhard
Dick Burkhard
GGGerd Geerling
Gerd Geerling
Zusammenfassung: Hintergrund Die okuläre Beteiligung bei vernarbendem Schleimhautpemphigoid (SHP) ist mit einer Prävalenz von 25 Fällen je 1 Mio. Einwohner und damit ca. 2100 Patienten in ganz Deutschland selten. Die Diagnosestellung kann – besonders in Abwesenheit anderer Beteiligungen – schwierig und die Therapie komplex und langwierig sein. Nicht selten kommen Immunsuppressiva zum Einsatz. Aufgrund der Komplexität von Diagnose und Therapie sind SHP-Patienten meist an entsprechend spezialisierte Zentren angebunden. Ziel dieses Projektes war die Erfassung der aktuellen augenärztlichen Versorgungssituation von Patienten mit SHP in Deutschland. Methoden Eine papierbasierte Umfrage wurde konzipiert und im April 2020 an alle Universitätsaugenkliniken und weitere potenzielle Zentren versandt. Gefragt wurde nach dem Bestehen einer spezialisierten Sprechstunde, der jährlichen Gesamtzahl der betreuten Patienten, der jährlichen Anzahl von neu diagnostizierten Patienten, den klinischen Kooperationspartnern in Diagnostik und Therapie sowie nach der angewendeten lokalen und systemischen Therapie. Ergebnisse Von insgesamt 44 angeschrieben Kliniken erfolgten 28 (64%) vollständige Rückmeldungen. Im Mittel werden in den Kliniken 27 ± 42 (0 – 200) Patienten betreut und jährlich pro Zentrum 3,6 ± 2,2 (0 – 10) neue Fälle diagnostiziert. Dies entspricht einer Gesamtpatientenzahl von 741 Patienten. Lediglich 9 (32%) der antwortenden Kliniken bieten eine spezialisierte SHP-Sprechstunde an. 93% der Zentren kooperieren mit der lokalen Klinik für Dermatologie. 79% führen die serologische und histologische Diagnostik intern durch. Etwa die Hälfte der Zentren (n = 16) wendet ein standardisiertes Therapieschema an. Systemisch werden Glukokortikoide (66,7%) am häufigsten verwendet, gefolgt von Mycophenolatmofetil und Dapson (57,1%), Rituximab (33,3%), Azathioprin und Cyclophosphamid (28,6%) sowie Methotrexat (19,0%). Am seltensten werden i. v. Immunoglobuline eingesetzt (14,3%). Schlussfolgerung Mit dieser Umfrage unter deutschen augenärztlichen Zentren wurden Daten von etwa einem Drittel der geschätzten Gesamtzahl aller in Deutschland an einem SHP erkrankten Menschen erhoben. Dabei handelt es sich vermutlich ausschließlich um Patienten mit mindestens einer okulären Beteiligung. Aktuell wird eine augenärztliche SHP-Registerstudie etabliert, um die Epidemiologie und Versorgungssituation besser zu erfassen und langfristig zu verbessern.

21 June 2024 in Archivos de la Sociedad Española de Oftalmología (English Edition)
Verified
Journal Article
Open access
RYR. Yaïci
R. Yaïci
RPRafael Martinez-Costa Perez
Rafael Martinez-Costa Perez
FLF. Lefebvre
F. Lefebvre
FNF. Muñoz Negrete
F. Muñoz Negrete
SDSorcha Ní Dhubhghaill
Sorcha Ní Dhubhghaill
TBTristan BOURCIER
Tristan BOURCIER
A survey conducted by the European Board of Ophthalmology (EBO) revealed significant differences in the surgical training of the ophthalmology residents in Europe, including a disparity between the sexes and a variation in the experience on cataract surgery (CC) between them. This study is about the Spanish sub-cohort of the survey, and its objective is to present and analyse the peculiarities of ophthalmology training in Spain within the European context, as well as discussing ways to harmonise and improve that training throughout the EU. We analyse data of the Spanish participants in the EBO exams, defining subgroups by the Autonomous Communities existing in Spain. 93 of 135 requested participants (68.9%) responded. A 60.2% passed the EBO exam between 2021-2022, being mostly women (65.59%) aged 31 years old on average. The 91.4% were right-handed, coming from 13 of the 17 Spanish autonomous communities, although mostly from the Community of Valencia, Madrid and Catalonia. Respectively, 16.1%, 3.2% and 8.7% of the respondents said they have completed 10 or more training sessions on animal eyes, synthetic eyes and through the virtual reality simulator. This training was correlated with greater self-confidence in the management of a posterior capsular tear during surgery (p .025). All respondents manifested to have already performed stages of the CC. The average number of operations reported was 181.6 with regional disparities. A significant difference is observed between the sexes against women (-28.3%, p 0.03). Ophthalmologists in Spain, much more than other European countries, have greater opportunities for surgical training, with surgical procedures during the residency, that nearly triples those made by the others. Spanish women refer, like their European colleagues, to be in disadvantage in learning opportunities about cataract surgery. The Simulation Based Medical Education (SBME) allows to respond to the training deficit and complements the training on the patient. Although we demonstrate a significant correlation between the number of procedures carried out and self-confidence to operate simple cases, the SBME would be a complementary tool in self-confidence in front of a complication like capsular rupture. Spain massively adopts the model named by us "surgery for all", despite the underrepresentation of women in this area, emphasising a need for cultural change that the SBME could facilitate.

7 August 2025 in Acta Ophthalmologica
Verified
Journal Article
Open access
HFHelena Prior Filipe
Helena Prior Filipe
RYRémi Yaïci
Rémi Yaïci
RIRenata Ivekovic
Renata Ivekovic
DCDenise Curtin
Denise Curtin
RARimvydas Asoklis
Rimvydas Asoklis
TBTristan BOURCIER
Tristan BOURCIER
Purpose: Ophthalmology encompasses comprehensive medical and surgical care for patients with diverse visual system disorders, significantly impacting eye health, vision, and quality of life. European ophthalmologists undergo specialized residency training to acquire necessary competencies, emphasizing theoretical knowledge, clinical and surgical skills, and professional behaviour. The European Union of Medical Specialists (UEMS) and the European Board of Ophthalmology (EBO) advocate for competency‐based medical education (CBME), standardized training frameworks, and harmonized assessments across Europe. Methods: In 2023, a survey among European ophthalmologists demonstrated broad consensus on establishing unified training requirements. Subsequently, a Core Working Group developed European Training Requirements (ETRs) for ophthalmology, detailing curricula, subspecialty rotations, and Entrustable Professional Activities (EPAs) across a structured four‐year residency. Results: These ETRs, formally approved by UEMS in October 2024, incorporate simulation‐based training, workplace‐based assessments (WPBA), and innovative evaluation methods such as electronic portfolios. Certification as a European Specialist in Ophthalmology involves passing rigorous summative assessments, including the European Board of Ophthalmology Diploma (EBOD) examination. Training institutions must offer substantial clinical exposure, robust infrastructure, and comprehensive educational resources. Faculty support, continuous quality assurance, regular audits, and clinical governance frameworks are essential. Conclusion: The ETRs also highlight the importance of interprofessional collaboration and encourage subspecialty expansion in emerging areas like ophthalmic oncology and global ophthalmology. Designed as a dynamic, “living document,” the ETRs will evolve with scientific and technological advancements, supporting high‐quality ophthalmic education and practice while respecting national diversity and sovereignty.